Skip to main content

Peer Review reports

From: The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy

Original Submission
9 Nov 2021 Submitted Original manuscript
23 Dec 2021 Author responded Author comments - Nicola Anne Thompson
Resubmission - Version 2
23 Dec 2021 Submitted Manuscript version 2
Publishing
24 Dec 2021 Editorially accepted
24 Jan 2022 Article published 10.1186/s12885-021-09156-x

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us